FSD Pharma Inc.(CSE: HUGE, OTCQB: FSDDF, Forum) announced on Monday that its shares have been approved to list on the Nasdaq Capital Market. The Company expects to commence trading on Nasdaq in the near future.
For more on this news, click here.
Coming up on Tuesday, FSD’s Executive Co-Chairman and Chief Executive Officer, Raza Bokhari, MD, will present an overview of the Company at the Investor Summit Conferencein Philadelphia.
FULL DISCLOSURE: FSD Pharma Inc. is a client of Stockhouse Publishing.